These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 795398)

  • 21. Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis.
    Wedlock DN; Denis M; Vordermeier HM; Hewinson RG; Buddle BM
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):50-8. PubMed ID: 17524495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The characterization and immunoreactivity of a 70 kD protein common to Mycobacterium leprae and Mycobacterium bovis (BCG).
    Britton WJ; Garsia RJ; Hellqvist L; Watson JD; Basten A
    Lepr Rev; 1986 Dec; 57 Suppl 2():67-75. PubMed ID: 3553805
    [No Abstract]   [Full Text] [Related]  

  • 23. [Obtaining the thermostabile seeding series of the Brazilian substrain BCG Moreau].
    Janaszek W
    Med Dosw Mikrobiol; 1982; 34(3-4):87-94. PubMed ID: 6763116
    [No Abstract]   [Full Text] [Related]  

  • 24. Stabilisation of BCG vaccines.
    Gheorghiu M; Lagranderie M; Balazuc AM
    Dev Biol Stand; 1996; 87():251-61. PubMed ID: 8854025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
    Niculescu D; Stavri D; Stavri H; Claiciu I; Bărbulescu R
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):213-9. PubMed ID: 6424629
    [No Abstract]   [Full Text] [Related]  

  • 27. [Purification, characterization and immunological study of 2 protein antigens of the BCG strain Mycobacterium bovis].
    De Bruyn J; Turneer M
    Bull Mem Acad R Med Belg; 1988; 143(1-2):157-70. PubMed ID: 3052672
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunological properties of attenuated tuberculosis strain "BK-Kharkov". I. The comparative characteristics of the structural lipids and their relationship to the immunogenic properties of the "BK-Kharkov" and BCG strains].
    Dikiĭ IL; Cherkas GP; Kandyba SG; Bykova VK
    Mikrobiol Zh; 1976; 38(3):325-30. PubMed ID: 820948
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
    Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
    Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunochemical analysis of the hydrosoluble antigens of the BCG vaccine and alt-tuberculin].
    Kulagin PP; Martynova VA
    Probl Tuberk; 1967; 45(9):74-7. PubMed ID: 4975371
    [No Abstract]   [Full Text] [Related]  

  • 32. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination.
    Marchant A; Goetghebuer T; Ota MO; Wolfe I; Ceesay SJ; De Groote D; Corrah T; Bennett S; Wheeler J; Huygen K; Aaby P; McAdam KP; Newport MJ
    J Immunol; 1999 Aug; 163(4):2249-55. PubMed ID: 10438968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of the study of the W 115 M. tuberculosis vaccine strain and the lyophilized experimental vaccine W 115.
    Weiszfeiler JG
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(4):492-7. PubMed ID: 812909
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of the secreted antigens of Mycobacterium bovis BCG: comparison of the 46-kilodalton dimeric protein with proteins MPB64 and MPB70.
    Abou-Zeid C; Harboe M; Rook GA
    Infect Immun; 1987 Dec; 55(12):3213-4. PubMed ID: 3316036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guérin vaccination in cattle.
    Vordermeier HM; Cockle PJ; Whelan AO; Rhodes S; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S291-8. PubMed ID: 10875803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrastructural mutants in BCG strains and their relation to immunogenicity.
    Mohelská H; Sír Z; Průchová J; Smerák P
    Dev Biol Stand; 1986; 58 ( Pt A)():95-102. PubMed ID: 3297880
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antigens common to human malignant tumors and certain species of microorganisms].
    Zhukov-Verezhnikov NN; Lomakin MS; Maĭskiĭ IN; Larin AS; Bochko GM
    Biull Eksp Biol Med; 1981 Sep; 92(9):331-3. PubMed ID: 6794672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG.
    Harboe M; Closs O; Svindahl K; Deverill J
    Infect Immun; 1977 May; 16(2):662-72. PubMed ID: 324917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
    Fan X; Gao Q; Fu R
    Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.